BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21679757)

  • 1. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
    Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
    Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idebenone loaded solid lipid nanoparticles: calorimetric studies on surfactant and drug loading effects.
    Sarpietro MG; Accolla ML; Puglisi G; Castelli F; Montenegro L
    Int J Pharm; 2014 Aug; 471(1-2):69-74. PubMed ID: 24845103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of percutaneous absorption of the repellent diethyltoluamide and the sunscreen ethylhexyl p-methoxycinnamate-loaded solid lipid nanoparticles: an in-vitro study.
    Puglia C; Bonina F; Castelli F; Micieli D; Sarpietro MG
    J Pharm Pharmacol; 2009 Aug; 61(8):1013-9. PubMed ID: 19703344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lipid microparticle encapsulation on in vitro efficacy, photostability and water resistance of the sunscreen agents, octyl methoxycinnamate and butyl methoxydibenzoylmethane.
    Trotta V; Goios F; Monteiro H; Almeida IF; Scalia S
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1233-9. PubMed ID: 23837520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
    Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
    J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of novel octylmethoxycinnamate-loaded solid lipid nanoparticles.
    Liu XH; Liang XZ; Fang X; Zhang WP
    Int J Cosmet Sci; 2015 Aug; 37(4):446-53. PubMed ID: 25720757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation.
    Scalia S; Mezzena M; Ramaccini D
    Skin Pharmacol Physiol; 2011; 24(4):182-9. PubMed ID: 21336009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles.
    Rivolta I; Panariti A; Lettiero B; Sesana S; Gasco P; Gasco MR; Masserini M; Miserocchi G
    J Physiol Pharmacol; 2011 Feb; 62(1):45-53. PubMed ID: 21451209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
    Wissing SA; Müller RH
    Pharmazie; 2001 Oct; 56(10):783-6. PubMed ID: 11683123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.